Franklin Resources
ENTA icon

Franklin Resources’s Enanta Pharmaceuticals ENTA Stock Holding History

Franklin Resources’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$846K Buy
66,947
+34,227
+105% +$459K ﹤0.01% 2244
2025
Q4 		$516K Buy
+32,720
New +$416K ﹤0.01% 2388
2024
Q4 		– Sell
-25,593
Closed -$289K – 2950
2024
Q3 		$289K Sell
25,593
-586
-2% -$7.66K ﹤0.01% 2503
2024
Q2 		$340K Sell
26,179
-2,887
-10% -$39K ﹤0.01% 2391
2024
Q1 		$507K Buy
+29,066
New +$385K ﹤0.01% 2238
2023
Q2 		– Sell
-4,994
Closed -$202K – 2735
2023
Q1 		$202K Sell
4,994
-31
-0.6% -$1.48K ﹤0.01% 2000
2022
Q4 		$234K Sell
5,025
-952
-16% -$43.4K ﹤0.01% 1952
2022
Q3 		$309K Buy
+5,977
New +$349K ﹤0.01% 1840
2022
Q1 		– Sell
-2,761
Closed -$206K – 2464
2021
Q4 		$206K Buy
+2,761
New +$217K ﹤0.01% 2231
2018
Q3 		– Sell
-268,025
Closed -$31.1M – 1524
2018
Q2 		$31.1M Sell
268,025
-17,775
-6% -$1.77M 0.02% 658
2018
Q1 		$23.1M Sell
285,800
-31,900
-10% -$2.46M 0.01% 745
2017
Q4 		$18.6M Buy
317,700
+117,700
+59% +$5.89M 0.01% 810
2017
Q3 		$9.36M Buy
+200,000
New +$8.04M ﹤0.01% 961
2014
Q1 		– Sell
-299,000
Closed -$8.16M – 1540
2013
Q4 		$8.16M Sell
299,000
-231,700
-44% -$5.62M ﹤0.01% 1035
2013
Q3 		$12.2M Buy
530,700
+50,800
+11% +$971K 0.01% 929
2013
Q2 		$8.5M Buy
+479,900
New +$9.36M ﹤0.01% 976

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Franklin Resources's ENTA Position: Q1 2026 in Review

Franklin Resources increased its Enanta Pharmaceuticals (ENTA) stake by 105% in Q1 2026, buying an estimated $459K and bringing the position to 66,947 shares worth $846K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

Franklin Resources first reported a position in ENTA in Q2 2013 and has held it in 16 quarters since. The position peaked at $31.1M in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Franklin Resources held 66,947 shares of Enanta Pharmaceuticals worth $846K as of Q1 2026.
  • Franklin Resources bought 34,227 Enanta Pharmaceuticals shares in Q1 2026, an estimated $459K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2244 holding.
  • Franklin Resources first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Franklin Resources's Enanta Pharmaceuticals position peaked at $31.1M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.